Chongqing Pharscin Pharmaceutical Co., Ltd.

SZSE:002907.SZ

16.07 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013
Revenue 774.82691.543785.183846.141882.474842.064703.415592.095551.667469.319425.904347.366
Cost of Revenue 331.051311.348319.292399.925458.306307.085230.77195.362196.575178.11154.388128.589
Gross Profit 443.769380.194465.891446.216424.168534.979472.645396.734355.092291.209271.516218.777
Gross Profit Ratio 0.5730.550.5930.5270.4810.6350.6720.670.6440.620.6380.63
Reseach & Development Expenses 59.12970.84558.82141.72236.47825.55815.2168.7044.0647.0088.6130
General & Administrative Expenses 9.6499.9138.1425.1212.49810.8097.5659.7495.8873.862.67422.215
Selling & Marketing Expenses 186.772210.74245.935258.591225.146290.789279.342239.258218.08179.039181.352159.784
SG&A 196.421262.285254.076263.711237.643301.598286.907249.006223.967182.899184.026181.999
Other Expenses 94.4180.51934.00234.16611.5246.7062.4361.32721.53717.28813.0849.997
Operating Expenses 349.969334.371346.9339.599285.645333.862314.347265.645256.696213.291209.239185.864
Operating Income 93.80145.823108.83103.312137.438198.262158.471131.05293.62973.47956.70427.588
Operating Income Ratio 0.1210.0660.1390.1220.1560.2350.2250.2210.170.1570.1330.079
Total Other Income Expenses Net -0.359-3.026-0.5890.108-0.389-0.272.4361.32519.82313.2813.0819.986
Income Before Tax 93.44242.797108.241103.42137.049197.992160.907132.379113.45186.7669.78637.573
Income Before Tax Ratio 0.1210.0620.1380.1220.1550.2350.2290.2240.2060.1850.1640.108
Income Tax Expense 16.71210.0989.8411.63917.86228.24623.53520.39117.74414.07210.4818.542
Net Income 76.7332.69998.40191.78119.187169.746137.372111.98795.70873.83658.75528.947
Net Income Ratio 0.0990.0470.1250.1080.1350.2020.1950.1890.1730.1570.1380.083
EPS 0.180.0780.240.230.30.420.340.310.270.210.730.08
EPS Diluted 0.180.0780.240.230.30.420.340.310.270.210.730.08
EBITDA 179.864125.848200.486192.96202.219230.945182.971153.884135.73109.61189.38533.797
EBITDA Ratio 0.2320.1820.2550.2280.2290.2740.260.260.2460.2340.210.097